Articlenpj drug discovery2024

Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity.

Lih-Yun Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.